SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001551986-20-000119
Filing Date
2020-05-04
Accepted
2020-05-04 19:00:19
Documents
2
Period of Report
2020-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_158863318519588.html 3  
1 FORM 3 wf-form3_158863318519588.xml 3 3568
2 POA MSIRGO 2020 ex-24.htm EX-24 3344
  Complete submission text file 0001551986-20-000119.txt   8536
Mailing Address C/O BIODELIVERY SCIENCES INTERNATIONAL 801 CORPORATE CENTER DRIVE -SUITE 210 RALEIGH NC 27607
Business Address
Sirgo Mark A (Reporting) CIK: 0001301715 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37797 | Film No.: 20846367

Mailing Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615
Business Address 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC 27615 919-275-1933
INNOVATE BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0001551986 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations